San Diego, CA, United States of America

Chaofeng Huang

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Chaofeng Huang

Introduction

Chaofeng Huang is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds related to monoacylglycerol lipase (MGL). With a total of five patents to his name, Huang's work has implications for various medical applications.

Latest Patents

Huang's latest patents include innovative compounds that have the potential to revolutionize imaging and treatment methodologies. One of his notable inventions is the "Radiolabelled MGL PET ligands." This invention relates to novel, selective, radiolabelled compounds that have MGL affinity. These compounds are useful for imaging and quantifying MGL receptor expression, distribution, and enzyme occupancy in tissues using positron-emission tomography (PET). The invention also encompasses compositions comprising such compounds, which can be used for imaging tissues, cells, or hosts, both in vitro and in vivo.

Another significant patent is focused on "Monoacylglycerol lipase modulators." This patent describes bridged compounds of specific formulas, along with pharmaceutical compositions containing them. The methods outlined in this patent include treating various disease states, disorders, and conditions associated with MGL modulation. These conditions include pain, psychiatric disorders, neurological disorders such as major depressive disorder, treatment-resistant depression, anxious depression, bipolar disorder, cancers, and eye conditions.

Career Highlights

Chaofeng Huang is currently employed at Janssen Pharmaceutica NV, where he continues to innovate and contribute to the field of pharmaceuticals. His work is characterized by a strong focus on the therapeutic potential of MGL modulation.

Collaborations

Huang has collaborated with notable colleagues, including Gang Chen and Michael K. Ameriks. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Chaofeng Huang's contributions to the field of pharmaceutical sciences through his innovative patents demonstrate his commitment to advancing medical research and treatment options. His work in developing MGL-related compounds holds promise for addressing various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…